Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXQN3L
|
||||
| Drug Name |
4-[(4-Chlorophenyl)methyl]-2-(2-{[4-(4-{[3-(hexahydro-1H-azepin-1-yl)propyl]oxy}phenyl)butyl]amino}ethyl)-1(2H)-phthalazinone
|
||||
| Synonyms |
CHEMBL1767162
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C36H45ClN4O2
|
||||
| Canonical SMILES |
Clc1ccc(CC2=NN(CCNCCCCc3ccc(OCCCN4CCCCCC4)cc3)C(=O)c5ccccc25)cc1
|
||||
| InChI |
InChI=1S/C36H45ClN4O2/c37-31-17-13-30(14-18-31)28-35-33-11-3-4-12-34(33)36(42)41(39-35)26-22-38-21-6-5-10-29-15-19-32(20-16-29)43-27-9-25-40-23-7-1-2-8-24-40/h3-4,11-20,38H,1-2,5-10,21-28H2
|
||||
| InChIKey |
UUYDLXMNWLLYQV-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
| Histamine H1 receptor | Target Info | [1587926] | |||
| PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.